Operating Expenses Lave om Dato
AbbVie USD 11.11B 540M 2023-12
Acorda Therapeutics USD 33.31M 427K 2023-06
Amgen USD 6.93B 2.11B 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
AstraZeneca USD 9.54B 578M 2023-09
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
Biogen USD 2.03B 344.1M 2023-12
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Enanta Pharmaceuticals USD 49.96M 5.64M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Heron Therapeutics USD 56.36M 17.8M 2023-09
Immunic USD 23.57M 1.45M 2023-09
Incyte USD 826.07M 121.75M 2023-12
Insmed USD 261.96M 35.22M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
J&J USD 16.57B 435M 2023-12
Ligand Pharmaceuticals USD 31.56M 1.77M 2023-12
Marinus Pharmaceuticals USD 38.98M 1.46M 2023-09
Merck USD 16.56B 6.35B 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Novavax USD 312.62M 56.35M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
PTC Therapeutics USD 438.79M 124.05M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Enanta Pharmaceuticals Driftsomkostninger - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.